One developer of a weight loss medication, clinical-stage biotech Structure Therapeutics ( GPCR 0.16%), was a victim of a ...
Telehealth stock Hims & Hers (HIMS) spiked more than 24% in trading Thursday, days after its Super Bowl ad promoting cheaper ...
Viewers of the Super Bowl may have seen an ad from one of the largest compounders in the United States, Hims & Hers, ...
Commercials run by the telehealth company Hims & Hers have been placed under the microscope as lawmakers are calling out ...
By: Katie Karlson and Madeline Darby Super Bowl commercials have been a cultural phenomenon for years. However, this year, one commercial sparked widespread controversy and a heated debate about the ...
The goal is to either have the put expire worthless and keep the premium, or to be assigned and acquire the stock below the current price.
Health-care companies rose amid hopes that one telehealth company's Superbowl advertising would pay off. Hims & Hers rallied after it aired an ad for alternative obesity-drugs that cast the telehealth ...
Erectile dysfunction (ED) is a common issue that affects millions of men, leading to a decline in quality of life and ...
Hims & Hers Health Inc is a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals, ...
Why does Hims seem to be able to ignore the statutes and rules that are enforced by the FDA and followed by every other ...